Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer GlobeNewswire February 03, 2026 Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of zovegalisib in combination with fulvestrant Initial Phase 1/2 data of zovegalisib + fulvestrant at the […]

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 GlobeNewswire February 03, 2026 BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the Guggenheim Emerging Outlook:

International Battery Metals Ltd. to Present at the OTC Precious Metals and Critical Minerals Conference

International Battery Metals Ltd. to Present at the OTC Precious Metals and Critical Minerals Conference GlobeNewswire February 03, 2026 VANCOUVER, British Columbia and HOUSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) — International Battery Metals Ltd. (“IBAT”) (TSXV: IBAT) & (OTCQB: IBATF), an advanced technology provider of modular direct lithium extraction (DLE) systems, today announced Joseph Mills,

Cyber Acoustics Expands Monitor-Mounted Speaker Bar Line with New CA-2890GX Featuring Dynamic LED Lights

Cyber Acoustics Expands Monitor-Mounted Speaker Bar Line with New CA-2890GX Featuring Dynamic LED Lights Perfect for casual gamers and anyone looking to add vibrant ambiance to their desktop setup GlobeNewswire February 03, 2026 VANCOUVER, Wash., Feb. 03, 2026 (GLOBE NEWSWIRE) — Cyber Acoustics, a leading provider of reliable and affordable audio solutions for 30 years,

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit GlobeNewswire February 03, 2026 WATERTOWN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) — Foghorn(R) Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 GlobeNewswire February 03, 2026 Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and patient-reported outcomes in patients with Charcot-Marie-Tooth disease (CMT) Benefits emerged early, were durable beyond treatment

Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program

Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program Cardiac dosing limit removed and path forward to dose selection identified GlobeNewswire February 03, 2026 LONDON and PHILADELPHIA, Feb. 03, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION(R), a tumor-activated oncology delivery platform, has published

Adlai Nortye Announces $140.0 Million Private Placement Equity Financing

Adlai Nortye Announces $140.0 Million Private Placement Equity Financing GlobeNewswire February 03, 2026 SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 03, 2026 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (Nasdaq: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it has entered into securities purchase agreements

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart(TM) and Advances Crown Medical Collections Initiative

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart(TM) and Advances Crown Medical Collections Initiative GlobeNewswire February 03, 2026 Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company's Balance Sheet UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech,

Pinewood.AI Debuts New AI Agent for Automated Dealership Tasks

Pinewood.AI Debuts New AI Agent for Automated Dealership Tasks New intelligence layer, code-named Project Intelligence (Pi), operates directly inside dealer systems, completing complex workflows without APIs or custom integrations GlobeNewswire February 03, 2026 LAS VEGAS, Feb. 03, 2026 (GLOBE NEWSWIRE) — Pinewood.AI, the leading cloud-based full-service technology provider to automotive retailers and OEMs, today announced

Scroll to Top